Neurocognition in Maraviroc- Compared to Tenofovir: A Double Blind Randomized Placebo Controlled Trial ACTG A5303

OBJECTIVE: To determine whether maraviroc (MVC) has unique neurocognitive benefits in the context of initial antiretroviral therapy (ART). DESIGN: Randomized, double-blind, placebo-controlled, 48-week trial SETTING: Participants were enrolled in US domestic ACTG clinical trial sites. PARTICIPANTS: 2...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:AIDS
Hoofdauteurs: Robertson, Kevin R., Miyahara, Sachiko, Lee, Anthony, Brown, Todd T., Chan, Ellen S., Berzins, Baiba, Rusin, David, Eron, Joseph J., Taiwo, Babafemi O.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014739/
https://ncbi.nlm.nih.gov/pubmed/27333088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001189
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items